Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Nashville TN, Atlanta GA, Germantown TN, Southhaven MS,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase 3, Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Nashville TN, Homewood AL, Memphis TN, St Louis MO,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase 2, Recruiting

LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

for
Degenerative Disc Disease, Lumbar Disc Disease, Spine Disease,
Location: Nashville TN, Fort Wayne IN, Pinehurst NC
Sponsor: Locate Bio Pty Ltd

Sex: All

Age: 22 - 70+

Code: NCT06462729

Phase 1, Phase 2, Recruiting

Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion

for
Degenerative Disc Disease, Spine Fusion, Back Pain
Location: Nashville TN, St Louis MO, Grand Rapids MI,
Sponsor: Kuros Biosurgery AG

Sex: All

Age: 18+

Code: NCT04679844

Recruiting

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

for
Myopia
Location: Nashville TN, Birmingham AL, Columbus OH, Durham NC,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 5 - 11

Code: NCT07095894

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

for
Epiretinal Membrane
Location: Nashville TN, Sandy Springs GA, Indianapolis IN,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 50+

Code: NCT05145491

Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Nashville TN, Huntsville AL, Paducah KY, Birmingham AL,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase 3, Recruiting
New

Corticosteroid for Diabetic Macular Edema (DME) Study

for
Diabetic Macular Edema (DME), Diabetic Retinopathy
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT07843849

Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

for
Acute Promyelocytic Leukemia (APL),
Location: Nashville TN, Birmingham AL, Lexington KY, Augusta GA,
Sponsor: Quetzal Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07504458

Phase 3, Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Smyrna TN, Bowling Green KY, Decatur GA,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase 1, Phase 2, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Nashville TN, Charlotte NC, Winston-Salem NC,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06158854

Phase 1, Phase 2, Recruiting

Intraoperative Monitoring (IOM) Patient Registry

for
Intraoperative Monitoring, Spinal Diseases
Location: Nashville TN
Sponsor: DC2 Healthcare

Sex: All

Age: 18+

Code: NCT02187653

Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Nashville TN, Sandy Springs GA, Cincinnati OH,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase 3, Recruiting

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

for
Macular Edema
Location: Nashville TN, Carmel IN, Wake Forest NC, Kansas City KS,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06962839

Phase 2, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for
Macular Edema Secondary to Inflammation
Location: Nashville TN, Carmel IN, St Louis MO, West Columbia SC,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase 3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: Nashville TN, Carmel IN, St Louis MO, West Columbia SC,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase 3, Recruiting

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

for
Diabetic Macular Edema
Location: Nashville TN, Wake Forest NC, Falls Church VA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07553429

Phase 1, Phase 2, Recruiting

Suprachoroidal Administration in Subjects With Metastases to the Choroid

for
Eye Cancer, Primary Cancer
Location: Nashville TN, Ann Arbor MI, Cleveland OH, Bellaire TX,
Sponsor: Aura Biosciences

Sex: All

Age: 18+

Code: NCT06643884

Phase 2, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Nashville TN, Greenville SC, Indianapolis IN, Carmel IN,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase 2, Recruiting

Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)

for
Stickler Syndrome Type 1, Stickler Syndrome Type 2
Location: Nashville TN, Birmingham AL, Royal Oak MI, Rochester MN,
Sponsor: Helen Keller Eye Research Foundation

Sex: All

Age: 0+

Code: NCT07146516

Recruiting